Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Clinical Opportunities at the Annual Meeting: A Fellow’s Perspective

Zsuzsanna McMahan, MD  |  

Over the years, the ACR/ARHP Annual Scientific Meeting has provided exceptional opportunities for all attendees, but it can be especially beneficial for rheumatology fellows, and this year’s annual meeting in Atlanta is no exception. The ACR Annual Meeting Planning Committee and the Fellows Subcommittee will facilitate several educational, mentoring, social, and networking programs specifically for the benefit of fellows.

Annual Scientific Meeting: Health Professionals’ Perspective

  |  

Rheumatology health professionals seeking continuing education should include the ACR/ARHP Annual Scientific Meeting on their list of must-attend meetings. No other conference offers more in rheumatic disease education and research, and this meeting provides a forum to network with over 11,000 physicians, scientists, and health professionals.

Unique Meeting Accelerates RA Research

  |  

More than 50 rheumatoid arthritis (RA) investigators from across the U.S. recently met in Ft. Worth, Texas, to share information, present data and results from their innovative RA research projects, and brainstorm ways to work more closely together to find a cure for the disease.

Congress Approves Six-Month “Doc Fix”—Now What?

  |  

Congress’ May 24 vote to rescind the 21% Medicare pay cut for six months illustrates how important it is for rheumatology professionals and patients to be involved in the legislative process. It was the thousands of calls, e-mails, and letters from medical professionals and patients that spurred Congress to take action. However, the battle is not yet over. Medicare physician payments face the same 21% cut beginning December 1.

The Key to Early Rheumatoid Arthritis

Annette H.M. van der Helm-van Mil, MD, PhD, and Tom W.J. Huizinga, MD, PhD  |  

The conundrum of classification versus diagnosis

What is ICD-9 Coding?

  |  

The International Classification of Diseases Clinical Modification, 9th Revision (ICD-9 CM) is a list of codes intended for the classification of diseases and a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or disease. The numerical format of the diagnosis codes usually ranges from three to five digits that are assigned to a unique category.